Class 8 Exam > Class 8 Questions > The supreme court of India has recently rejec...
Start Learning for Free
The supreme court of India has recently rejected a Swiss based Pharma company's plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?
- a)Novartis
- b)Galderma
- c)Anavex Life Sciences
- d)Fenjal
Correct answer is option 'A'. Can you explain this answer?
| FREE This question is part of | Download PDF Attempt this Test |
Most Upvoted Answer
The supreme court of India has recently rejected a Swiss based Pharma ...
Company: Novartis
Background:
- Novartis is a Swiss-based pharmaceutical company.
- They had applied for a patent for their blood cancer drug Glivec in India.
- The company wanted to prevent Indian companies from manufacturing generic versions of the drug.
Ruling:
- The Supreme Court of India rejected Novartis' plea for the patent and to restrain Indian companies from manufacturing generics.
- The court stated that Novartis' application did not meet the criteria of novelty or inventiveness required for a patent.
- The court also clarified that the Indian patent law allows for the production of affordable generics to ensure access to essential medicines.
Impact:
- The rejection of Novartis' plea allows Indian companies to continue manufacturing and selling generic versions of Glivec.
- This decision has significant implications for access to affordable medication, particularly for patients suffering from blood cancer.
- It reinforces India's stance on promoting generic drug manufacturing and ensuring affordable healthcare for its population.
Conclusion:
- The Supreme Court of India rejected Novartis' plea for a patent on their blood cancer drug Glivec and to restrain Indian companies from manufacturing generics.
- This decision upholds India's position on promoting affordable healthcare and access to essential medicines.
Background:
- Novartis is a Swiss-based pharmaceutical company.
- They had applied for a patent for their blood cancer drug Glivec in India.
- The company wanted to prevent Indian companies from manufacturing generic versions of the drug.
Ruling:
- The Supreme Court of India rejected Novartis' plea for the patent and to restrain Indian companies from manufacturing generics.
- The court stated that Novartis' application did not meet the criteria of novelty or inventiveness required for a patent.
- The court also clarified that the Indian patent law allows for the production of affordable generics to ensure access to essential medicines.
Impact:
- The rejection of Novartis' plea allows Indian companies to continue manufacturing and selling generic versions of Glivec.
- This decision has significant implications for access to affordable medication, particularly for patients suffering from blood cancer.
- It reinforces India's stance on promoting generic drug manufacturing and ensuring affordable healthcare for its population.
Conclusion:
- The Supreme Court of India rejected Novartis' plea for a patent on their blood cancer drug Glivec and to restrain Indian companies from manufacturing generics.
- This decision upholds India's position on promoting affordable healthcare and access to essential medicines.
Attention Class 8 Students!
To make sure you are not studying endlessly, EduRev has designed Class 8 study material, with Structured Courses, Videos, & Test Series. Plus get personalized analysis, doubt solving and improvement plans to achieve a great score in Class 8.
|
Explore Courses for Class 8 exam
|
|
Top Courses for Class 8View all
The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer?
Question Description
The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? for Class 8 2024 is part of Class 8 preparation. The Question and answers have been prepared according to the Class 8 exam syllabus. Information about The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? covers all topics & solutions for Class 8 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer?.
The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? for Class 8 2024 is part of Class 8 preparation. The Question and answers have been prepared according to the Class 8 exam syllabus. Information about The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? covers all topics & solutions for Class 8 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer?.
Solutions for The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? in English & in Hindi are available as part of our courses for Class 8.
Download more important topics, notes, lectures and mock test series for Class 8 Exam by signing up for free.
Here you can find the meaning of The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of
The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer?, a detailed solution for The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? has been provided alongside types of The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? theory, EduRev gives you an
ample number of questions to practice The supreme court of India has recently rejected a Swiss based Pharma companys plea for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs.Which among the following is that company?a)Novartisb)Galdermac)Anavex Life Sciencesd)FenjalCorrect answer is option 'A'. Can you explain this answer? tests, examples and also practice Class 8 tests.
|
|
Explore Courses for Class 8 exam
|
|
Suggested Free Tests
Signup for Free!
Signup to see your scores go up within 7 days! Learn & Practice with 1000+ FREE Notes, Videos & Tests.
|
© EduRev
|
Education Revolution
|
Follow Us
|
Signup to see your scores
go up within 7 days!
Access 1000+ FREE Docs, Videos and Tests
Takes less than 10 seconds to signup